1. Home
  2. GLMD vs BNBX Comparison

GLMD vs BNBX Comparison

Compare GLMD & BNBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Galmed Pharmaceuticals Ltd.

GLMD

Galmed Pharmaceuticals Ltd.

BUY

Current Price

$0.74

Market Cap

4.4M

Sector

Health Care

ML Signal

BUY

BNBX

Applied DNA Sciences Inc.

N/A

Current Price

$0.59

Market Cap

3.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
GLMD
BNBX
Founded
2000
1983
Country
Israel
United States
Employees
N/A
26
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.4M
3.6M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
GLMD
BNBX
Price
$0.74
$0.59
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.8M
39.1K
Earning Date
05-21-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$253.12
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$0.57
52 Week High
$2.67
$6.17

Technical Indicators

Market Signals
Indicator
GLMD
BNBX
Relative Strength Index (RSI) 63.49 28.57
Support Level $0.46 N/A
Resistance Level $0.87 $0.85
Average True Range (ATR) 0.10 0.06
MACD 0.03 0.00
Stochastic Oscillator 38.28 5.36

Price Performance

Historical Comparison
GLMD
BNBX

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

About BNBX Applied DNA Sciences Inc.

BNB Plus Corp focuses on digital asset treasury management of BNB. The group is unlocking institutional-grade access to the Binance ecosystem, delivering non-directional yield strategies and long BNB exposure, powering the future of blockchain through a transparent, actively managed BNB treasury. The Company's differentiated blends sophisticated DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded from the space.

Share on Social Networks: